Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. - Wikidata - wikimedia - TriplyDB

Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

http://www.wikidata.org/entity/Q37364992

about

Insulin and oral agents for managing cystic fibrosis-related diabetes Appetite stimulants for people with cystic fibrosis Insulin and oral agents for managing cystic fibrosis-related diabetes Update on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD)A Practical Approach to Glucose Abnormalities in Cystic Fibrosis Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.Diabetes as a determinant of mortality in cystic fibrosis.Impaired fasting glucose in cystic fibrosis Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis.Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex Diabetes research: a perspective from the National Institute of Diabetes and Digestive and Kidney Diseases.Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes Oral glucose tolerance testing in children with cystic fibrosis.Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.Update in cystic fibrosis 2010.Malnutrition in cystic fibrosis: a review.CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.Diagnosing cystic fibrosis-related diabetes: current methods and challenges.The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.Predictors of deterioration of lung function in Polish children with cystic fibrosis.Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry.Elevation of one hour plasma glucose during oral glucose tolerance testing.Clinical care guidelines: too much of a good thing?Hypoglycemia in adults with cystic fibrosis during oral glucose tolerance testing.Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test?Pharmacological management of cystic fibrosis related diabetes.Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges.Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes.Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial

P2860

Q24185897-75D5285C-D0D5-4516-B76E-8D2FA9F561A1 Q24194798-D8F9A934-8FD7-492A-8E16-82A00F2DCDCC Q24201034-2F892770-3A84-4587-8C23-324C8F27B1BD Q26830633-DF14285C-F9CC-4E9B-9A44-C2427755AE63 Q28067394-C161F351-ACBA-4B0D-A534-F336C9E5587F Q33602084-BF7E4AA0-9F10-4DAA-AB5C-10DEE4132C63 Q33602207-EEA39450-0C8A-41C3-B3E1-F31C934548EC Q34351881-9B42D94D-291B-4142-B2F8-7AC80C91C0E2 Q34351912-A56464C0-200A-4678-968D-4F0EB106DC1E Q34351928-A366C25F-A57B-4EAA-99C7-35EAE9948A98 Q34507044-DBAFEAA7-26C9-4815-B25F-9F78EF65B4BA Q35118399-3EE073E7-71F9-4E5B-A174-53E8245012AB Q35140718-25BDFEAB-1C44-4F55-B116-0D7CE552F0B3 Q36560539-7C8ACD89-2EDA-4DA8-93D8-2D11FB23832A Q36720341-E5479176-308E-4D78-B3C3-9221F237CA4D Q37239325-30268738-04D5-43F6-9FE6-1D9514CC47B8 Q37377703-F420E260-D9D8-4F1E-BE8E-A34BC589ED3D Q37483419-2A5C38B6-BA20-44DD-A84F-75CBA153E270 Q37882620-EDEAB42D-4AF4-497C-85EB-6644EED2A0D5 Q37892766-2AF30454-DED4-4032-A370-F13D415A5363 Q38156392-A5BF0AB2-C747-4210-B4B4-F2385CE0122A Q38656600-02458C67-9790-477A-A521-3566C19F99AE Q38781600-0C1F2509-1B38-4D7C-AD79-FA71157C3793 Q38857042-A7599738-6C06-4B92-9929-F01B9FF73254 Q38980646-A72CBF39-E301-4B30-8073-F7E9054C432D Q39761233-9BA24B29-1E79-45E0-90C6-DA5B887D93E3 Q41048772-F5932E28-9FF1-4B03-9FAA-8A8B2DA99DAC Q41659595-CCC52360-08F4-4FB4-92DF-7794CFCBAD48 Q42343499-6541AFC3-B683-45C9-8B56-033FE7344CA5 Q43087675-0E15B383-5F62-41E8-B4C7-8D13F2ACDDF7 Q44881953-B13657BD-B1C6-4916-9392-2405FA46F03A Q47266208-19FDE4E9-0DF3-46BD-8BDF-65619F9307FB Q48123950-3BF0D724-B8EE-4D67-8E73-BAECDA4C2374 Q52739000-B2DD3625-50E8-406B-85D8-608A95345701 Q54265700-8782B0F2-823E-43CC-80A3-0AAA6903E6BC

P2860

Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

http://www.wikidata.org/entity/Q37364992

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Insulin therapy to improve BMI ...... elated diabetes therapy trial.

@en

Insulin therapy to improve BMI ...... elated diabetes therapy trial.

@nl

type

label

Insulin therapy to improve BMI ...... elated diabetes therapy trial.

@en

Insulin therapy to improve BMI ...... elated diabetes therapy trial.

@nl

prefLabel

Insulin therapy to improve BMI ...... elated diabetes therapy trial.

@en

Insulin therapy to improve BMI ...... elated diabetes therapy trial.

@nl

P1433

Q37364992-A7125E02-8200-4D8F-8212-ED68714F1A68

P1476

Q37364992-83E7E6D5-CE30-440D-8158-3E854B86DA8C

P2093

Q37364992-074C8D27-9839-4D21-8203-407B06488438

Q37364992-127EF9F5-EE98-41E9-A742-B2D85896B236

Q37364992-5F4096F7-820C-4D66-90A2-035918B66620

Q37364992-76A10CB5-00F9-44DD-B794-594808115A88

Q37364992-83A39862-19C5-4E43-9E4A-FCCAB5D1E9E6

Q37364992-901B591D-B9FD-445C-AF9D-0B092478C926

Q37364992-DCC20584-F71F-4769-BE6D-660951BE8173

Q37364992-EBB152C9-C3D6-4B79-A425-D9AD189420E7

Q37364992-EC740C71-9183-40E0-9991-B8FED6685EA5

Q37364992-F6796F0C-348C-49D9-9D87-B787FDC12A35

P2860

Q37364992-0605787C-9F70-4399-B6CA-BBAEC2590B90

Q37364992-299E345A-D6BF-4FFB-95A9-882744D1C5F6

Q37364992-300B1F51-FDEB-46D7-BD49-E7D2AEB0F361

Q37364992-34854FC4-CBF3-4092-BCEA-F47A76F77A56

Q37364992-396E5394-C011-499A-9228-33BA6755E7E7

Q37364992-42724956-F1D1-4C2D-8B1E-4FFA4A2B6AB6

Q37364992-48BA4688-2B69-432C-BA0E-6E3A8E761EDA

Q37364992-4D6D4662-303A-4982-9D6E-9CF79761C3E6

Q37364992-64A64CFC-1489-4318-B68A-E8024120D209

Q37364992-719C001A-B825-42B8-A3A6-C0380240CEE3

P304

Q37364992-59510E1C-E173-4077-B0D1-E453B4C1E775

P31

Q37364992-7FB80050-3F98-48B4-9BB4-6908342B255B

P356

Q37364992-69E78C9C-9F8B-44DF-B969-7DCB4E266886

P407

Q37364992-158EA693-C327-4172-98E0-B837B74E6184

P433

Q37364992-00324DB5-0ED8-4DE2-A69A-38A90F91793A

P478

Q37364992-A7EEA43F-9286-44BB-B243-711544DDD132

P577

Q37364992-0501A43B-D0C1-41A9-AEF5-48DE37EB9E8A

P5875

Q37364992-77343E00-883E-47A7-B6E3-8D5697BC7491

P698

Q37364992-D5B5B26F-9019-43A0-8477-DC0B205E68EA

P921

Q37364992-6B68AEEC-6474-4F34-8911-E858C4422BCD

Q37364992-934A3CB3-59F8-4E5B-9313-94FE8E8DFD01

Q37364992-B48CA5D7-5784-4009-B1B9-05E346D0C0FF

P932

Q37364992-DA0B312B-10FF-4D68-B38F-19F38B037495

P356

P1433

P1476

Insulin therapy to improve BMI ...... elated diabetes therapy trial.

@en

P2093

Antoinette Moran

http://www.w3.org/2001/XMLSchema#string

Bonnie Slovis

http://www.w3.org/2001/XMLSchema#string

Cystic Fibrosis Related Diabetes Therapy Study Group

http://www.w3.org/2001/XMLSchema#string

Elizabeth Tullis

http://www.w3.org/2001/XMLSchema#string

Holley Allen

http://www.w3.org/2001/XMLSchema#string

Joseph Pilewski

http://www.w3.org/2001/XMLSchema#string

Martha Zorn

http://www.w3.org/2001/XMLSchema#string

Patricia Grover

http://www.w3.org/2001/XMLSchema#string

Penelope Pekow

http://www.w3.org/2001/XMLSchema#string

Theodore G Liou

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report.

Determinants of adherence in adults with cystic fibrosis.

Microvascular complications in cystic fibrosis-related diabetes.

Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline.

A new prognostic score and clinical evaluation system for cystic fibrosis.

Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance.

Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus.

Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.

Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.

Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.

P304

1783-1788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-0585

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26661576

http://www.w3.org/2001/XMLSchema#string

P698

19592632

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

2752940

http://www.w3.org/2001/XMLSchema#string